157 related articles for article (PubMed ID: 35328017)
1. A Clinical Investigation on the Theragnostic Effect of MicroRNA Biomarkers for Survival Outcome in Cervical Cancer: A PRISMA-P Compliant Protocol for Systematic Review and Comprehensive Meta-Analysis.
Shaw P; Senthilnathan R; Sankar S; Ilangovan I; Kodiveri Muthukaliannan G; Baxi S; Mani RR; Rajagopal M; Chinnappan S; Balaraman AK; Suresh D; Krishnan S; Gupta M; Muthusamy T; Paranjothy C; Jayaraj R
Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328017
[TBL] [Abstract][Full Text] [Related]
2. Molecular Investigation of miRNA Biomarkers as Chemoresistance Regulators in Melanoma: A Protocol for Systematic Review and Meta-Analysis.
Shaw P; Raymond G; Tzou KS; Baxi S; Mani RR; Kumar Govind S; Chandramoorthy HC; Sivanandy P; Rajagopal M; Samiappan S; Krishnan S; Jayaraj R
Genes (Basel); 2022 Jan; 13(1):. PubMed ID: 35052456
[TBL] [Abstract][Full Text] [Related]
3. Clinical Investigation of Chemotherapeutic Resistance and miRNA Expressions in Head and Neck Cancers: A Thorough PRISMA Compliant Systematic Review and Comprehensive Meta-Analysis.
Jayaraj R; Polpaya K; Kunale M; Kodiveri Muthukaliannan G; Shetty S; Baxi S; Mani RR; Paranjothy C; Purushothaman V; Kayarohanam S; Janakiraman AK; Balaraman AK
Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553594
[No Abstract] [Full Text] [Related]
4. Clinical Theragnostic Relationship between Chemotherapeutic Resistance, and Sensitivity and miRNA Expressions in Head and Neck Cancers: A Systematic Review and Meta-Analysis Protocol.
Shaw P; Raymond G; Senthilnathan R; Kumarasamy C; Baxi S; Suresh D; Shetty S; Ram M R; Chandramoorthy HC; Sivanandy P; Samiappan S; Rajagopal M; Krishnan S; Jayaraj R
Genes (Basel); 2021 Dec; 12(12):. PubMed ID: 34946979
[No Abstract] [Full Text] [Related]
5. Clinical Theragnostic Potential of Diverse miRNA Expressions in Prostate Cancer: A Systematic Review and Meta-Analysis.
Jayaraj R; Raymond G; Krishnan S; Tzou KS; Baxi S; Ram MR; Govind SK; Chandramoorthy HC; Abu-Khzam FN; Shaw P
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32397507
[No Abstract] [Full Text] [Related]
6. Prognostic miRNA classifiers in t cell acute lymphoblastic leukemia: Study protocol for a systematic review and meta-analysis of observational clinical studies.
Sabarimurugan S; Madurantakam Royam M; Kumarasamy C; Kodiveri Muthukaliannan G; Samiappan S; Jayaraj R
Medicine (Baltimore); 2019 Mar; 98(9):e14569. PubMed ID: 30817574
[TBL] [Abstract][Full Text] [Related]
7. Clinical Theragnostic Relationship between Drug-Resistance Specific miRNA Expressions, Chemotherapeutic Resistance, and Sensitivity in Breast Cancer: A Systematic Review and Meta-Analysis.
Jayaraj R; Nayagam SG; Kar A; Sathyakumar S; Mohammed H; Smiti M; Sabarimurugan S; Kumarasamy C; Priyadharshini T; Gothandam KM; Ramesh N; Gupta A; Baxi S; Swamiappan S; Krishnan S
Cells; 2019 Oct; 8(10):. PubMed ID: 31615089
[TBL] [Abstract][Full Text] [Related]
8. Role of microRNAs in Predicting the Prognosis of Cervical Cancer Cases: A Systematic Review and Meta-Analysis.
Sabeena S; Ravishankar N
Asian Pac J Cancer Prev; 2021 Apr; 22(4):999-1006. PubMed ID: 33906290
[TBL] [Abstract][Full Text] [Related]
9. Validation of miRNA prognostic significance in stage II colorectal cancer: A protocol for systematic review and meta-analysis of observational clinical studies.
Sabarimurugan S; Kumarasamy C; Madurantakam Royam M; Lakhotiya K; Kodiveri Muthukaliannan G; Ramalingam S; Jayaraj R
Medicine (Baltimore); 2019 Mar; 98(12):e14570. PubMed ID: 30896613
[TBL] [Abstract][Full Text] [Related]
10. Cervical cancer development, chemoresistance, and therapy: a snapshot of involvement of microRNA.
Mitra T; Elangovan S
Mol Cell Biochem; 2021 Dec; 476(12):4363-4385. PubMed ID: 34453645
[TBL] [Abstract][Full Text] [Related]
11. A Clinical Update on the Prognostic Effect of microRNA Biomarkers for Survival Outcome in Nasopharyngeal Carcinoma: A Systematic Review and Meta-Analysis.
Shaw P; Senthilnathan R; Krishnan S; Suresh D; Shetty S; Muthukaliannan GK; Mani RR; Sivanandy P; Chandramoorthy HCK; Gupta MM; Baxi S; Jayaraj R
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503179
[No Abstract] [Full Text] [Related]
12. microRNAs: New prognostic, diagnostic, and therapeutic biomarkers in cervical cancer.
Nahand JS; Taghizadeh-Boroujeni S; Karimzadeh M; Borran S; Pourhanifeh MH; Moghoofei M; Bokharaei-Salim F; Karampoor S; Jafari A; Asemi Z; Tbibzadeh A; Namdar A; Mirzaei H
J Cell Physiol; 2019 Aug; 234(10):17064-17099. PubMed ID: 30891784
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of microRNAs in cervical carcinoma: a systematic review and meta-analysis.
Dai S; Lu Y; Long Y; Lai Y; Du P; Ding N; Yao D
Oncotarget; 2016 Jun; 7(23):35369-78. PubMed ID: 27177085
[TBL] [Abstract][Full Text] [Related]
14. Systematic review and meta-analysis of prognostic microRNA biomarkers for survival outcome in nasopharyngeal carcinoma.
Sabarimurugan S; Kumarasamy C; Baxi S; Devi A; Jayaraj R
PLoS One; 2019; 14(2):e0209760. PubMed ID: 30735523
[TBL] [Abstract][Full Text] [Related]
15. Systematic Review and Meta-analysis of the Prognostic Significance of miRNAs in Melanoma Patients.
Sabarimurugan S; Madurantakam Royam M; Das A; Das S; K M G; Jayaraj R
Mol Diagn Ther; 2018 Dec; 22(6):653-669. PubMed ID: 30259393
[TBL] [Abstract][Full Text] [Related]
16. Potential role of microRNAs in the treatment and diagnosis of cervical cancer.
Shen S; Zhang S; Liu P; Wang J; Du H
Cancer Genet; 2020 Oct; 248-249():25-30. PubMed ID: 32987255
[TBL] [Abstract][Full Text] [Related]
17. Current Evidence on miRNAs as Potential Theranostic Markers for Detecting Chemoresistance in Colorectal Cancer: A Systematic Review and Meta-Analysis of Preclinical and Clinical Studies.
Madurantakam Royam M; Kumarasamy C; Baxi S; Gupta A; Ramesh N; Kodiveri Muthukaliannan G; Jayaraj R
Mol Diagn Ther; 2019 Feb; 23(1):65-82. PubMed ID: 30726546
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of MicroRNAs in Stage II Colorectal Cancer Patients: A Systematic Review and Meta-Analysis.
Sabarimurugan S; Madhav MR; Kumarasamy C; Gupta A; Baxi S; Krishnan S; Jayaraj R
Mol Diagn Ther; 2020 Feb; 24(1):15-30. PubMed ID: 32020560
[TBL] [Abstract][Full Text] [Related]
19. The potential prognostic and therapeutic application of tissue and circulating microRNAs in cervical cancer.
Hasanzadeh M; Movahedi M; Rejali M; Maleki F; Moetamani-Ahmadi M; Seifi S; Hosseini Z; Khazaei M; Amerizadeh F; Ferns GA; Rezayi M; Avan A
J Cell Physiol; 2019 Feb; 234(2):1289-1294. PubMed ID: 30191988
[TBL] [Abstract][Full Text] [Related]
20. Circulating MicroRNAs as Prognostic Molecular Biomarkers in Human Head and Neck Cancer: A Systematic Review and Meta-Analysis.
Lamichhane SR; Thachil T; Gee H; Milic N
Dis Markers; 2019; 2019():8632018. PubMed ID: 31827646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
